WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
+7.97%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$4.61B
AUM Growth
+$1.15B
(+33%)
Cap. Flow
+$942M
Cap. Flow
% of AUM
20.44%
Top 10 Holdings %
Top 10 Hldgs %
14.99%
Holding
712
New
195
Increased
177
Reduced
107
Closed
146
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$73.4M |
| 2 |
Alibaba
BABA
|
$62.2M |
| 3 |
Altria Group
MO
|
$57.8M |
| 4 |
Bank of America
BAC
|
$44M |
| 5 |
Citigroup
C
|
$43.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$111M |
| 2 |
BPL
Buckeye Partners, L.P.
BPL
|
$75.6M |
| 3 |
VICI Properties
VICI
|
$57.7M |
| 4 |
DRE
Duke Realty Corp.
DRE
|
$40.6M |
| 5 |
Healthcare Realty
HR
|
$40.4M |
Sector Composition
| 1 | Technology | 17.89% |
| 2 | Real Estate | 16.36% |
| 3 | Industrials | 11.18% |
| 4 | Healthcare | 8.74% |
| 5 | Financials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
401
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.19M | 0.02% |
15,000
+5,000
| +50% | +$397K |
|
402
Lennar Class A
LEN
$36.7B
| $1.18M | 0.02% |
+21,817
| New | +$1.18M |
|
403
Lowe's Companies
LOW
$151B
| $1.18M | 0.02% |
9,812
-24,687
| -72% | -$2.96M |
|
404
MPLX
MPLX
$51.5B
| $1.17M | 0.02% |
+46,000
| New | +$1.17M |
|
405
Aldeyra Therapeutics
ALDX
$334M
| $1.16M | 0.02% |
200,000
| – | – |
|
406
Exact Sciences
EXAS
$10.2B
| $1.16M | 0.02% |
+12,500
| New | +$1.16M |
|
407
Kemper
KMPR
$3.39B
| $1.16M | 0.02% |
+14,900
| New | +$1.16M |
|
408
Public Service Enterprise Group
PEG
$40.5B
| $1.14M | 0.02% |
+19,300
| New | +$1.14M |
|
409
Las Vegas Sands
LVS
$36.9B
| $1.14M | 0.02% |
16,500
-110,741
| -87% | -$7.64M |
|
410
Stryker
SYK
$150B
| $1.11M | 0.02% |
5,288
+288
| +6% | +$60.5K |
|
411
ATI
ATI
$10.7B
| $1.1M | 0.02% |
+53,179
| New | +$1.1M |
|
412
Sarepta Therapeutics
SRPT
$1.96B
| $1.1M | 0.02% |
8,500
+500
| +6% | +$64.5K |
|
413
Insmed
INSM
$30.7B
| $1.08M | 0.02% |
45,000
+6,000
| +15% | +$143K |
|
414
Rigel Pharmaceuticals
RIGL
$742M
| $1.07M | 0.02% |
50,000
-1,000
| -2% | -$21.4K |
|
415
Idacorp
IDA
$6.77B
| $1.07M | 0.02% |
+10,000
| New | +$1.07M |
|
416
Ciena
CIEN
$16.5B
| $1.07M | 0.02% |
25,000
-240,000
| -91% | -$10.2M |
|
417
Opko Health
OPK
$1.07B
| $1.03M | 0.02% |
700,000
+675,000
| +2,700% | +$992K |
|
|
ITCI
418
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.03M | 0.02% |
30,000
| – | – |
|
|
TPIC
419
DELISTED
TPI Composites
TPIC
| $1.02M | 0.02% |
+55,000
| New | +$1.02M |
|
420
TechnipFMC
FTI
$16B
| $1.01M | 0.02% |
+63,168
| New | +$1.01M |
|
421
Box
BOX
$4.75B
| $1.01M | 0.02% |
60,000
-165,000
| -73% | -$2.77M |
|
422
IDEX
IEX
$12.4B
| $1M | 0.02% |
+5,840
| New | +$1M |
|
423
Mastercard
MA
$528B
| $993K | 0.02% |
+3,324
| New | +$993K |
|
|
ALBO
424
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $941K | 0.02% |
37,000
+2,000
| +6% | +$50.9K |
|
425
Winnebago Industries
WGO
$1.03B
| $901K | 0.01% |
+17,000
| New | +$901K |
|